Scalable and physiologically relevant microenvironments for human pluripotent stem cell expansion and differentiation

Human pluripotent stem cells (hPSCs) are required in large numbers for various biomedical applications. However, the scalable and cost-effective culturing of high quality hPSCs and their derivatives remains very challenging. Here, we report a novel and physiologically relevant 3D culture system (called the AlgTube cell culture system) for hPSC expansion and differentiation. With this system, cells are processed into and cultured in microscale alginate hydrogel tubes that are suspended in the cell culture medium in a culture vessel. The hydrogel tubes protect cells from hydrodynamic stresses in the culture vessel and limit the cell mass smaller than 400 μm in diameter to ensure efficient mass transport, creating cell-friendly microenvironments for growing cells. This system is simple, scalable, highly efficient, defined and compatible with the current good manufacturing practices. Under optimized culture conditions, the AlgTubes enabled long-term culture of hPSCs (>10 passages, >50 days) with high cell viability, high growth rate (1000-fold expansion over 10 days per passage), high purity (>95% Oct4+) and high yield (5.0 × 108 cells ml-1), all of which offer considerable advantages compared to current approaches. Moreover, the AlgTubes enabled directed differentiation of hPSCs into various tissue cells. This system can be readily scaled to support research from basic biological study to clinical development and the future industry-scale production.

[1]  Shoji Takeuchi,et al.  Metre-long cell-laden microfibres exhibit tissue morphologies and functions. , 2013, Nature materials.

[2]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[3]  Adrian Ranga,et al.  Defined three-dimensional microenvironments boost induction of pluripotency. , 2016, Nature materials.

[4]  L. Studer,et al.  Adapting human pluripotent stem cells to high-throughput and high-content screening , 2012, Nature Protocols.

[5]  Marta M. Silva,et al.  Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization , 2015, Stem cells translational medicine.

[6]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[7]  Qiulian Wu,et al.  A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. , 2016, Cancer research.

[8]  U. Demirci,et al.  Bioprinting for stem cell research. , 2013, Trends in biotechnology.

[9]  S. Nishikawa,et al.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells , 2007, Nature Biotechnology.

[10]  Robert Langer,et al.  Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[11]  Praveen Shukla,et al.  Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. , 2015, Stem cell research.

[12]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[13]  Vladimir Mironov,et al.  Tissue spheroid fusion‐based in vitro screening assays for analysis of tissue maturation , 2010, Journal of tissue engineering and regenerative medicine.

[14]  Liang Ma,et al.  Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. , 2015, Biomaterials.

[15]  T. Baer,et al.  Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage , 2010, Nature Biotechnology.

[16]  Korkut Uygun,et al.  Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. , 2011, Annual review of biomedical engineering.

[17]  C. Mason,et al.  Scale-up of human embryonic stem cell culture using a hollow fibre bioreactor , 2012, Biotechnology Letters.

[18]  Diana Nada Caterina Massai,et al.  Progress and challenges in large-scale expansion of human pluripotent stem cells , 2017 .

[19]  F. Wurm Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[20]  D. Mooney,et al.  Alginate: properties and biomedical applications. , 2012, Progress in polymer science.

[21]  M. Spector,et al.  Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.

[22]  Robert Langer,et al.  Three-dimensional biomaterials for the study of human pluripotent stem cells , 2011, Nature Methods.

[23]  Y. Lei,et al.  Three-dimensional tissues using human pluripotent stem cell spheroids as biofabrication building blocks , 2017, Biofabrication.

[24]  K. Sidhu,et al.  Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. , 2010, Biomaterials.

[25]  Robert Zweigerdt,et al.  Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single‐Use Stirred Tank Bioreactors , 2016, Stem cells translational medicine.

[26]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[27]  Charles E. Murry,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[28]  David V. Schaffer,et al.  A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation , 2013, Proceedings of the National Academy of Sciences.

[29]  Yuguo Lei,et al.  Developing Defined and Scalable 3D Culture Systems for Culturing Human Pluripotent Stem Cells at High Densities , 2014, Cellular and molecular bioengineering.

[30]  Melissa A. Kinney,et al.  Hydrodynamic modulation of pluripotent stem cells , 2012, Stem Cell Research & Therapy.

[31]  R. McKay,et al.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. , 2014, Cell stem cell.

[32]  Anne L Plant,et al.  Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015 , 2016, Regenerative medicine.

[33]  Anja Lode,et al.  Direct Plotting of Three‐Dimensional Hollow Fiber Scaffolds Based on Concentrated Alginate Pastes for Tissue Engineering , 2013, Advanced healthcare materials.

[34]  Elena Naumovska,et al.  Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells , 2015, Stem cell reports.

[35]  Interwoven Four-Compartment Capillary Membrane Technology for Three-Dimensional Perfusion with Decentralized Mass Exchange to Scale Up Embryonic Stem Cell Culture , 2010, Cells Tissues Organs.

[36]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[37]  Michael R. King 2013 BMES Outstanding Contributions , 2014 .

[38]  Catarina Brito,et al.  Process engineering of human pluripotent stem cells for clinical application. , 2012, Trends in biotechnology.

[39]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[40]  Suzanne S Farid,et al.  Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies , 2014, Biotechnology journal.

[41]  R. McKay,et al.  Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation. , 2014, Stem cell research.

[42]  A. Lindahl,et al.  Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells , 2011, Cytotechnology.

[43]  Robert Zweigerdt,et al.  Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture , 2014, Stem cell reports.

[44]  Wee Keat Chong,et al.  Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays. , 2014, Biotechnology journal.

[45]  Praveen Shukla,et al.  Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.

[46]  P. Itsykson,et al.  Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension , 2010, Nature Biotechnology.

[47]  Andreas Fouras,et al.  Flow Characterization of a Spinner Flask for Induced Pluripotent Stem Cell Culture Application , 2014, PloS one.

[48]  M. Hartman,et al.  Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. , 2016, Advanced drug delivery reviews.

[49]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[50]  Y. Lei,et al.  An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells , 2017, Scientific Reports.

[51]  Robert Zweigerdt,et al.  Large-scale production of human pluripotent stem cell derived cardiomyocytes. , 2016, Advanced drug delivery reviews.

[52]  P. Alves,et al.  Microencapsulation Technology: A Powerful Tool for Integrating Expansion and Cryopreservation of Human Embryonic Stem Cells , 2011, PloS one.

[53]  J. Gerlach,et al.  Periodic harvesting of embryonic stem cells from a hollow‐fiber membrane based four‐compartment bioreactor , 2016, Biotechnology progress.

[54]  Todd C McDevitt,et al.  The multiparametric effects of hydrodynamic environments on stem cell culture. , 2011, Tissue engineering. Part B, Reviews.

[55]  Alan Faulkner-Jones,et al.  Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D , 2015, Biofabrication.

[56]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.